Recent News

• 04.24.2025 - Merit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance
• 04.09.2025 - Merit Medical Launches the Ventrax™ Delivery System
• 04.07.2025 - Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025
• 03.27.2025 - Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD
• 03.25.2025 - Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)
• 03.18.2025 - Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership
• 03.10.2025 - First Patient Enrolled in Merit Medical’s PREEMIE Study

Recent Filings

• 04.24.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.24.2025 - EX-99.1 EX-99.1
• 04.24.2025 - 8-K Current report
• 04.14.2025 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - 144 Report of proposed sale of securities
• 04.01.2025 - DEF 14A Other definitive proxy statements
• 04.01.2025 - ARS Annual Report to Security Holders
• 04.01.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 03.25.2025 - 144 Report of proposed sale of securities